W. Schuyler Jones - Concepedia

Author

W. Schuyler Jones

Also Known As

Albert Seymour, David J. Engel, Etienne Puymirat, Fleg, Jerome L., Iqbal, N., Jens Eldrup-Jorgensen, Matthew T Roe, R Johnston, Soumitra Sengupt, W JONES

380

Publications

14.9K

Citations

H-Index

108

Concepts

All Affiliations

Clinical Research Institute Duke University Duke Medical Center Stanford University University of Colorado Denver

About

W. Schuyler Jones is an author at Clinical Research Institute specializing in medicine, cardiovascular disease, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	51	5K
2	Public Health	18	27	1.6K
3	Health Sciences	3	3	124
4	Allergy	1	1	11
5	Biochemistry	1	1	13

W. Schuyler Jones

134

Publications

11.6K

Citations

H-Index

Page 1

	Year	Citations
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, The Lancet Diabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2	2018	1.7K
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines Eric M. Isselbacher, Ourania Preventza, James H. Black, Circulation	2022	1.6K
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease William R. Hiatt, F. Gerry R. Fowkes, Gretchen Heizer, New England Journal of Medicine	2016	618
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease Eric M. Isselbacher, Ourania Preventza, James H. Black, Journal of the American College of Cardiology Vascular DiseaseCardiovascular DiseaseAortic DiseasesAortic DiseasePeripheral Artery Disease	2022	450
Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease Manesh R. Patel, Michael S. Conte, Donald E. Cutlip, Journal of the American College of Cardiology ThrombosisCardiovascular DiseasePeripheral InterventionLower Extremity WoundVascular Surgery	2015	358
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly, The Lancet ThrombosisDose-finding Phase 2Cardiovascular DiseasePharmacologyCardiovascular Pharmacology	2022	296
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease W. Schuyler Jones, Hillary Mulder, Lisa Wruck, New England Journal of Medicine	2021	285
Empagliflozin after Acute Myocardial Infarction Javed Butler, W. Schuyler Jones, Jacob A. Udell, New England Journal of Medicine	2024	223
High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease W. Schuyler Jones, Manesh R. Patel, David Dai, American Heart Journal AmputationLimb ReconstructionMedicare PatientsCardiovascular DiseaseHigh Mortality Risks	2013	217
Temporal Trends and Geographic Variation of Lower-Extremity Amputation in Patients With Peripheral Artery Disease W. Schuyler Jones, Manesh R. Patel, David Dai, Journal of the American College of Cardiology AmputationCardiovascular DiseaseTemporal TrendsLower Extremity WoundLower Limb Trauma	2012	184

Page 1